Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free DHT.UN Stock Alerts

DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$17.39 -0.07 (-0.40%)
As of 09:41 AM Eastern
Compare

DHT.UN vs. BHC, CRON, GUD, THCX, and TLRY

Should you buy DRI Healthcare Trust stock or one of its competitors? MarketBeat compares DRI Healthcare Trust with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DRI Healthcare Trust include Bausch Health Companies (BHC), Cronos Group (CRON), Knight Therapeutics (GUD), Hydropothecary (THCX), and Tilray Brands (TLRY). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does DRI Healthcare Trust compare to Bausch Health Companies?

DRI Healthcare Trust (TSE:DHT.UN) and Bausch Health Companies (TSE:BHC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

DRI Healthcare Trust currently has a consensus target price of C$24.80, suggesting a potential upside of 42.61%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, equities research analysts clearly believe DRI Healthcare Trust is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

DRI Healthcare Trust has a beta of 0.385191, indicating that its share price is 61% less volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.973491, indicating that its share price is 3% less volatile than the broader market.

DRI Healthcare Trust has higher earnings, but lower revenue than Bausch Health Companies. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M5.84C$9.73M-C$0.90N/A
Bausch Health CompaniesC$10.53B0.23-C$125.65M-C$3.24N/A

DRI Healthcare Trust has a net margin of 5.02% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat DRI Healthcare Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Bausch Health Companies -13.54%120.43%4.16%

In the previous week, Bausch Health Companies had 7 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 7 mentions for Bausch Health Companies and 0 mentions for DRI Healthcare Trust. Bausch Health Companies' average media sentiment score of 0.86 beat DRI Healthcare Trust's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company Overall Sentiment
DRI Healthcare Trust Neutral
Bausch Health Companies Positive

0.8% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 10.7% of Bausch Health Companies shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

DRI Healthcare Trust beats Bausch Health Companies on 9 of the 17 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

Cronos Group (TSE:CRON) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of -1.29%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-1.29% -0.19% -3.73%
DRI Healthcare Trust 5.02%2.06%4.22%

Cronos Group has a beta of 1.126226, indicating that its stock price is 13% more volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.385191, indicating that its stock price is 61% less volatile than the broader market.

4.3% of Cronos Group shares are held by institutional investors. Comparatively, 0.8% of DRI Healthcare Trust shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cronos Group presently has a consensus price target of C$4.75, indicating a potential upside of 18.45%. DRI Healthcare Trust has a consensus price target of C$24.80, indicating a potential upside of 42.61%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

DRI Healthcare Trust has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$159.54M9.39-C$32.78MN/AN/A
DRI Healthcare TrustC$163.77M5.84C$9.73M-C$0.90N/A

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled DRI Healthcare Trust'saverage media sentiment score.

Company Overall Sentiment
Cronos Group Neutral
DRI Healthcare Trust Neutral

Summary

DRI Healthcare Trust beats Cronos Group on 10 of the 14 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

Knight Therapeutics has a beta of -0.206788, indicating that its share price is 121% less volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.385191, indicating that its share price is 61% less volatile than the broader market.

23.0% of Knight Therapeutics shares are owned by institutional investors. Comparatively, 0.8% of DRI Healthcare Trust shares are owned by institutional investors. 45.6% of Knight Therapeutics shares are owned by insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DRI Healthcare Trust has lower revenue, but higher earnings than Knight Therapeutics. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Knight TherapeuticsC$510.45M1.88-C$30.73MC$0.06162.50
DRI Healthcare TrustC$163.77M5.84C$9.73M-C$0.90N/A

In the previous week, Knight Therapeutics' average media sentiment score of 0.00 equaled DRI Healthcare Trust'saverage media sentiment score.

Company Overall Sentiment
Knight Therapeutics Neutral
DRI Healthcare Trust Neutral

Knight Therapeutics currently has a consensus price target of C$9.50, suggesting a potential downside of 2.56%. DRI Healthcare Trust has a consensus price target of C$24.80, suggesting a potential upside of 42.61%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Knight Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Knight Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

DRI Healthcare Trust has a net margin of 5.02% compared to Knight Therapeutics' net margin of 1.10%. DRI Healthcare Trust's return on equity of 2.06% beat Knight Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Knight Therapeutics1.10% 0.73% 0.51%
DRI Healthcare Trust 5.02%2.06%4.22%

Summary

DRI Healthcare Trust beats Knight Therapeutics on 10 of the 15 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Hydropothecary?

DRI Healthcare Trust (TSE:DHT.UN) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Hydropothecary N/A N/A N/A

DRI Healthcare Trust has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M5.84C$9.73M-C$0.90N/A
HydropothecaryN/AN/AN/AN/AN/A

0.8% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

DRI Healthcare Trust currently has a consensus target price of C$24.80, suggesting a potential upside of 42.61%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, research analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, DRI Healthcare Trust's average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
DRI Healthcare Trust Neutral
Hydropothecary Neutral

Summary

DRI Healthcare Trust beats Hydropothecary on 10 of the 10 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Tilray Brands?

DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

0.8% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 4.4% of Tilray Brands shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M5.84C$9.73M-C$0.90N/A
Tilray BrandsC$858.28M0.82-C$183.24M-C$14.63N/A

DRI Healthcare Trust currently has a consensus price target of C$24.80, indicating a potential upside of 42.61%. Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 134.15%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than DRI Healthcare Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Tilray Brands had 1 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for DRI Healthcare Trust. DRI Healthcare Trust's average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score.

Company Overall Sentiment
DRI Healthcare Trust Neutral
Tilray Brands Neutral

DRI Healthcare Trust has a beta of 0.385191, indicating that its stock price is 61% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.0845, indicating that its stock price is 208% more volatile than the broader market.

DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -158.75%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Tilray Brands -158.75%-88.06%-1.41%

Summary

DRI Healthcare Trust beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

Export
MetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$956.73MC$2.25BC$6.90BC$12.23B
Dividend Yield3.34%2.81%2.67%6.19%
P/E Ratio-19.325.0727.1636.92
Price / Sales5.841,646.36521.559.42
Price / CashN/A10.1826.3982.29
Price / Book1.879.9810.264.39
Net IncomeC$9.73MC$20.27BC$3.60BC$299.09M
7 Day Performance-3.39%-0.81%-0.31%0.84%
1 Month Performance-0.34%-0.25%-1.78%0.37%
1 Year Performance18.70%6.77%18.20%30.55%

DRI Healthcare Trust Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
2.0498 of 5 stars		C$17.39
-0.4%		C$24.80
+42.6%		+19.2%C$956.73MC$163.77MN/AN/A
BHC
Bausch Health Companies
0.7277 of 5 stars		C$6.78
-2.3%		N/A-32.7%C$2.53BC$10.53BN/A19,900
CRON
Cronos Group
1.8052 of 5 stars		C$3.92
+1.0%		C$4.75
+21.2%		+41.8%C$1.46BC$159.54MN/A450
GUD
Knight Therapeutics
N/AC$9.82
+1.3%		C$9.50
-3.3%		+58.2%C$964.12MC$510.45M163.67725
THCX
Hydropothecary
N/AC$5.30
+6.6%		N/A+0.0%C$949.11MN/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:DHT.UN) was last updated on 7/27/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel